Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Stanford Medcast: Expert Voices in Medicine and Healthcare cover art

Stanford Medcast: Expert Voices in Medicine and Healthcare

Stanford Medcast: Expert Voices in Medicine and Healthcare

Written by: Stanford University School of Medicine
Listen for free

About this listen
From groundbreaking science to practice-changing insights, Stanford Medcast brings you the ideas shaping the future of medicine and healthcare. Each episode features leading physicians and scientists sharing expertise on the latest research, innovations, and clinical challenges—designed for busy clinicians on the go. Hosted by Ruth Adewuya, MD, the podcast spotlights timely, high-impact topics clinicians care about most—from advances in oncology, dermatology, and maternal health to the latest in artificial intelligence, leadership, and health equity. Episodes deliver quick, practical takeaways backed by Stanford expertise. Subscribe now to access conversations that matter: what’s new, what’s next, and how it impacts clinical practice. Discover more at medcast.stanford.edu. Produced by the Stanford Center for Continuing Medical Education.Copyright 2025 All rights reserved. Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Episode 125: Antibiotic Resistance: What Prescribing Can't Explain
    Nov 17 2026

    Antimicrobial resistance is a growing global health threat, but how much of the problem can antibiotic overuse actually explain? What happens when resistant bacteria spread through communities, even among people with little or no exposure to healthcare settings?

    In this episode of Stanford Medcast, Dr. Ruth Adewuya speaks with Dr. Ashley Styczynski, an infectious disease physician and medical officer at the Centers for Disease Control and Prevention, about what research across multiple countries is revealing about antibiotic resistance. Drawing on her work in Bangladesh and other global settings, Dr. Styczynski explores why antibiotic use that may appear inappropriate can be a rational response to limited diagnostic and treatment options, and how sanitation, environmental conditions, and community transmission contribute to the spread of resistant organisms.

    The conversation also examines what these global findings mean for clinicians in the United States, from recognizing international healthcare exposures and identifying patients at risk for resistant infections to making informed empiric treatment decisions and knowing when to narrow or discontinue antibiotics. Together, they explore why addressing antimicrobial resistance requires looking beyond the prescription to the broader conditions that shape infection risk, transmission, and clinical care.

    Read Transcript: https://mcdn.podbean.com/mf/web/r4fm48gvbsxvifng/Transcript_medcast_Episode125.pdf

    CME Information: https://stanford.cloud-cme.com/medcastepisode125

    Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=4273

    Show More Show Less
    33 mins
  • Episode 124: Lung Nodules: Why the Next Step Matters
    Nov 3 2026

    A lung nodule appears on a CT scan. What happens next? Should the patient undergo additional imaging, have a biopsy, or be referred to a specialist? And how might those decisions shape the path to diagnosis and treatment?

    In this episode of Stanford Medcast, Dr. Ruth Adewuya speaks with Stanford interventional pulmonologist Dr. Pranjal Patel about the clinical decisions that follow the discovery of a suspicious lung nodule. They explore advances in lung biopsy techniques, the importance of coordinating diagnosis and staging, and why obtaining a tissue diagnosis is only one part of the process.

    The conversation also examines how emerging technologies and more coordinated approaches to care may improve the diagnostic pathway for patients with suspected lung cancer.

    Read Transcript: https://mcdn.podbean.com/mf/web/9mh97g8ej5ubmtr8/Transcript_medcast_episode124.pdf

    CME Information: https://stanford.cloud-cme.com/medcastepisode124

    Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=4210

    Show More Show Less
    32 mins
  • Episode 123: How Precise Can Cancer Treatment Get?
    Oct 20 2026

    Proton therapy can deliver radiation with remarkable precision, limiting exposure to healthy tissue beyond a tumor. But does more precise always mean better care, and if the technology has been available for decades, why do so few patients have access to it?

    In this episode of Stanford Medcast, host Dr. Ruth Adewuya speaks with Dr. Billy Loo, professor of radiation oncology at Stanford Medicine, about the evolving role of proton therapy in cancer care. They explore how proton therapy differs from conventional radiation, which patients may benefit most, and why technological advantages do not always translate directly into better clinical outcomes. Dr. Loo also takes listeners inside the development of Stanford Medicine’s ultracompact proton therapy system, an approach designed to bring a technology once requiring a massive, dedicated facility into an existing cancer center. He discusses what a smaller footprint could mean for access, the importance of multidisciplinary expertise in determining the right treatment for each patient, and the barriers that remain. Looking ahead, the conversation turns to FLASH radiotherapy and the possibility that delivering radiation in fractions of a second could add a new dimension to precision cancer treatment, potentially changing not only where radiation is delivered, but how healthy tissue responds to it.

    Read Transcript: https://mcdn.podbean.com/mf/web/xip9itq4y4h473c2/Transcript_medcast_episode123.pdf

    CME Information: https://stanford.cloud-cme.com/medcastepisode123

    Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=4192

    Show More Show Less
    37 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet